Start-up · Leeds
NIQS Tech is building a needle-free glucose monitor that uses a patented photonic chip and an optical measurement technique designed to reduce the effect of skin tone and thickness on readings. The Leeds company's founders trained at the University of Leeds, and Innovate UK has funded its sensor development, including in-vivo studies from April 2024. Early human testing on 12 people, reported in July 2025, gave 97.5% of readings in the most accurate zone of the DTS error grid. NIQS became a partner in the Q-BIOMED quantum biomedical sensing hub in November 2025.
Founded in 2022, NIQS Tech is a start-up in Leeds focused on quantum sensing and photonics. It is a partner in 1 UK project: Q-BIOMED. Profiled here: Nicholas Furtak-Wells (CEO).
Sources: NIQS Tech · In-vivo studies of a quantum optical glucose sensor | UKRI Gateway to Research · NIQS delivers non-invasive glucose monitoring with 99.3% accuracy | NIQS Tech · NIQS named latest Q-BIOMED partner | NIQS Tech
Q-BIOMED
A national research hub that develops quantum sensors for earlier diagnosis of disease. UCL and the University of Cambridge lead it.
Role: Partner
Funding: £24m
Themes: Sensing, Biomedical and health, Imaging
Recent articles from Quantum Zeitgeist that mention NIQS Tech.
The field of drug design is rapidly advancing thanks to significant breakthroughs in hardware and error correction. Funding from the National Quantum Technology Programme is expected to support further research and commercialization of applications, particularly in healthcare. A new report from UKRI
Image © Quantum Zeitgeist
Chosen by shared specialisms, then location and type.
Start-up · Glasgow · 2 shared specialisms
Company · Nottingham · 2 shared specialisms
Company · Southampton · 2 shared specialisms
Company · Didcot · 2 shared specialisms
Company data from Entangled Future. News from Quantum Zeitgeist. Last checked 2 October 2026.
Logos and names are trademarks of their respective owners, used to identify them. No endorsement implied.
